SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001104659-22-053625
Filing Date
2022-04-29
Accepted
2022-04-29 16:26:52
Documents
1
Period of Report
2021-08-05

Document Format Files

Seq Description Document Type Size
1 OWNERSHIP DOCUMENT tm2213913-10_4seq1.html 4  
1 OWNERSHIP DOCUMENT tm2213913-10_4seq1.xml 4 11064
  Complete submission text file 0001104659-22-053625.txt   12589
Mailing Address 1111 KANE CONCOURSE SUITE 301 BAY HARBOR ISLANDS FL 33154
Business Address 1111 KANE CONCOURSE SUITE 301 BAY HARBOR ISLANDS FL 33154 781-652-4500
Fortress Biotech, Inc. (Issuer) CIK: 0001429260 (see all company filings)

IRS No.: 205157386 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address C/O FORTRESS BIOTECH, INC. 3 COLUMBUS CIRCLE, 15TH FLOOR NEW YORK NY 10019
Business Address
Klein Dov (Reporting) CIK: 0001647971 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-35366 | Film No.: 22876029